Late-Breaking Clinical Trials Signal New Therapeutic Options for Many Patients in the Near Term
December 12, 2017
December 12, 2017
ATLANTA, Georgia, Dec. 12 -- The American Society of Hematology issued the following news release:
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment. The announcements reflect the latest results from clinical trial data collected . . .
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment. The announcements reflect the latest results from clinical trial data collected . . .